These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 18793006

  • 1. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories.
    Pincus T, Swearingen CJ, Bergman M, Yazici Y.
    J Rheumatol; 2008 Nov; 35(11):2136-47. PubMed ID: 18793006
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience.
    Singh H, Gupta V, Ray S, Kumar H, Talapatra P, Kaur M, Kumar S, Arya S, Mathur R, Ghangas N.
    Clin Rheumatol; 2012 Dec; 31(12):1663-9. PubMed ID: 22983768
    [Abstract] [Full Text] [Related]

  • 3. Can RAPID3, an index without formal joint counts or laboratory tests, serve to guide rheumatologists in tight control of rheumatoid arthritis in usual clinical care?
    Pincus T.
    Bull NYU Hosp Jt Dis; 2009 Dec; 67(3):254-66. PubMed ID: 19852747
    [Abstract] [Full Text] [Related]

  • 4. RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) clinical trial of certolizumab pegol.
    Pincus T, Furer V, Keystone E, Yazici Y, Bergman MJ, Luijtens K.
    Arthritis Care Res (Hoboken); 2011 Aug; 63(8):1142-9. PubMed ID: 21485024
    [Abstract] [Full Text] [Related]

  • 5. RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds.
    Pincus T, Swearingen CJ, Bergman MJ, Colglazier CL, Kaell AT, Kunath AM, Siegel EL, Yazici Y.
    Arthritis Care Res (Hoboken); 2010 Feb; 62(2):181-9. PubMed ID: 20191516
    [Abstract] [Full Text] [Related]

  • 6. Proposed severity and response criteria for Routine Assessment of Patient Index Data (RAPID3): results for categories of disease activity and response criteria in abatacept clinical trials.
    Pincus T, Hines P, Bergman MJ, Yazici Y, Rosenblatt LC, MacLean R.
    J Rheumatol; 2011 Dec; 38(12):2565-71. PubMed ID: 22089467
    [Abstract] [Full Text] [Related]

  • 7. Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort.
    Castrejón I, Dougados M, Combe B, Guillemin F, Fautrel B, Pincus T.
    J Rheumatol; 2013 Apr; 40(4):386-93. PubMed ID: 23378463
    [Abstract] [Full Text] [Related]

  • 8. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care.
    Pincus T, Yazici Y, Bergman MJ.
    Rheum Dis Clin North Am; 2009 Nov; 35(4):773-8, viii. PubMed ID: 19962621
    [Abstract] [Full Text] [Related]

  • 9. An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures.
    Pincus T, Bergman MJ, Yazici Y, Hines P, Raghupathi K, Maclean R.
    Rheumatology (Oxford); 2008 Mar; 47(3):345-9. PubMed ID: 18238788
    [Abstract] [Full Text] [Related]

  • 10. Validation of RAPID3 using a Japanese version of Multidimensional Health Assessment Questionnaire with Japanese rheumatoid arthritis patients: characteristics of RAPID3 compared to DAS28 and CDAI.
    Yokogawa N, Kaneko T, Nagai Y, Nunokawa T, Sawaki T, Shiroto K, Shimada K, Sugii S.
    Mod Rheumatol; 2015 Mar; 25(2):264-9. PubMed ID: 25156777
    [Abstract] [Full Text] [Related]

  • 11. Pragmatic and scientific advantages of MDHAQ/ RAPID3 completion by all patients at all visits in routine clinical care.
    Pincus T, Yazici Y, Castrejón I.
    Bull NYU Hosp Jt Dis; 2012 Mar; 70 Suppl 1():30-6. PubMed ID: 23259656
    [Abstract] [Full Text] [Related]

  • 12. One-year maintenance with routine assessment of patient index data 3-based remission may inhibit radiographic progression in patients with rheumatoid arthritis treated with routine clinical therapy: A retrospective comparison of radiographic outcome and its prognostic factors between maintained remissions with patient-reported outcome index and physician-oriented disease activity indices.
    Katayama K, Okubo T, Sato T, Kamiya K, Fukai R, Abe S, Ito H, Makino Y, Kamishima T.
    Mod Rheumatol; 2016 Nov; 26(6):817-827. PubMed ID: 26915909
    [Abstract] [Full Text] [Related]

  • 13. Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores.
    Yazici Y, Bergman M, Pincus T.
    J Rheumatol; 2008 Apr; 35(4):603-9. PubMed ID: 18322993
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of Disease Activity Score in 28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) & Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation.
    Kumar BS, Suneetha P, Mohan A, Kumar DP, Sarma KVS.
    Indian J Med Res; 2017 Nov; 146(Supplement):S57-S62. PubMed ID: 29578196
    [Abstract] [Full Text] [Related]

  • 16. Performance of routine assessment of patient index data 3 (RAPID3) in monitoring disease activity of Chinese rheumatoid arthritis patients.
    Zhang X, Xie A, Wang Y, Deng X, Geng Y, Ji L, Hao Y, Li G, Zhang Z.
    Int J Rheum Dis; 2018 Nov; 21(11):1940-1945. PubMed ID: 30402934
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate.
    Castrejón I, Pincus T, Soubrier M, Lin YC, Rat AC, Combe B, Dougados M.
    Rheumatology (Oxford); 2013 Oct; 52(10):1890-7. PubMed ID: 23864169
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical value of MDHAQ for disease activity assessment in patients with rheumatoid arthritis].
    Yang M, Wang Y, Xie QB, Cen XR, Yin G.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):285-8. PubMed ID: 25924447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.